CervoMed
CRVO
50 hedge funds and large institutions have $51.2M invested in CervoMed in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 3 closing their positions.
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
32% more funds holding
Funds holding: 38 → 50 (+12)
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
0.71% more ownership
Funds ownership: 41.78% → 42.49% (+0.71%)
13% less capital invested
Capital invested by funds: $59M → $51.2M (-$7.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$2.09M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$832K |
| 3 |
Morgan Stanley
New York
|
+$580K |
| 4 |
State Street
Boston,
Massachusetts
|
+$355K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$302K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$3.69M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$542K |
| 3 |
Bank of New York Mellon
New York
|
-$236K |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$177K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$158K |
CRVO Hedge Fund Activity: Q3 2024 in Review
50 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2024, worth a combined $51.2M — down 13% from $59M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CRVO positions and 3 closed out — a net gain of 12 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was AWM Investment Company, adding an estimated $2.09M. The largest seller was Armistice Capital, cutting an estimated $3.69M.
- 50 institutional investors held CervoMed (CRVO) as of Q3 2024, up from 38 in Q2 2024.
- Funds reported $51.2M of CervoMed stock for Q3 2024, down 13% quarter-over-quarter.
- 15 funds opened new CervoMed positions in Q3 2024 and 3 closed out, a net change of +12 holders.
- The largest CervoMed buyer in Q3 2024 was AWM Investment Company, an estimated $2.09M added.
- The largest CervoMed seller in Q3 2024 was Armistice Capital, an estimated $3.69M sold.
Based on aggregated 13F filings for Q3 2024.